These Numbers Could Change Investor Views For Ocugen Inc (NASDAQ: OCGN)

Currently, there are 256.50M common shares owned by the public and among those 250.87M shares have been available to trade.

The company’s stock has a 5-day price change of -6.10% and 172.71% over the past three months. OCGN shares are trading 167.83% year to date (YTD), with the 12-month market performance up to 74.52% higher. It has a 12-month low price of $0.34 and touched a high of $2.11 over the same period. OCGN has an average intraday trading volume of 7.80 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 28.51%, 73.76%, and 169.37% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Ocugen Inc (NASDAQ: OCGN) shares accounts for 10.22% of the company’s 256.50M shares outstanding.

It has a market capitalization of $395.01M and a beta (3y monthly) value of 3.52. The earnings-per-share (ttm) stands at -$0.32. Price movements for the stock have been influenced by the stock’s volatility, which stands at 18.57% over the week and 13.45% over the month.

Analysts forecast that Ocugen Inc (OCGN) will achieve an EPS of -$0.06 for the current quarter, -$0.06 for the next quarter and -$0.28 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.07 while analysts give the company a high EPS estimate of -$0.06. Comparatively, EPS for the current quarter was -$0.1 a year ago. Earnings per share for the fiscal year are expected to increase by 1.75%, and 7.14% over the next financial year.

Looking at the support for the OCGN, a number of firms have released research notes about the stock. Chardan Capital Markets stated their Buy rating for the stock in a research note on March 01, 2023, with the firm’s price target at $3.50. Mizuho coverage for the Ocugen Inc (OCGN) stock in a research note released on August 23, 2022 offered a Buy rating with a price target of $5. ROTH Capital was of a view on June 15, 2022 that the stock is Buy, while Cantor Fitzgerald gave the stock Overweight rating on June 02, 2022, issuing a price target of $4.50. Noble Capital Markets on their part issued Outperform rating on July 26, 2021.

Most Popular

Related Posts